Nath Bio-Genes (India) Ltd
BSE: 537291
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 322.84+606.5% | 45.69-30.7% | 65.96+65.9% | 39.77-85.8% | 280.17+659.8% | 36.87+14.5% | 32.19-86.8% | 243.88 |
| Other Income | 1.90-20.0% | 2.38+36.8% | 1.74-10.3% | 1.93+9.7% | 1.76+269.1% | 0.48+624.2% | 0.07-52.5% | 0.14 |
| Total Income | 324.74+575.6% | 48.07-29.0% | 67.70+62.3% | 41.70-85.2% | 281.94+654.8% | 37.35+15.8% | 32.26-86.8% | 244.01 |
| EXPENSES | ||||||||
| Expenditure | 292.57+579.8% | 43.04-30.9% | 62.28+68.9% | 36.86-85.0% | 245.13+630.5% | 33.56+14.1% | 29.40-86.0% | 209.88 |
| Tax | 0.72-71.2% | 2.50+186.4% | 0.87+36.1% | 0.64-2.8% | 0.66-42.1% | 1.14+3971.4% | 0.03-88.6% | 0.24 |
| PROFIT | ||||||||
| PBT | 33.38+430.9% | 6.29-22.4% | 8.10+67.4% | 4.84-87.5% | 38.87+924.1% | 3.79+32.6% | 2.86-91.6% | 34.13 |
| Net Profit | 32.66+762.1% | 3.79-47.6% | 7.23+72.1% | 4.20-89.0% | 38.21+1339.0% | 2.65-8.1% | 2.89-91.5% | 33.89 |
| KEY METRICS | ||||||||
| OPM % | 11.24%-5.98pp | 17.22%-0.25pp | 17.47%-0.60pp | 18.07%+3.45pp | 14.62%+16.99pp | -2.37%+0.65pp | -3.02%-15.70pp | 12.68% |
| NPM % | 10.06%+2.18pp | 7.88%-2.80pp | 10.68%+0.61pp | 10.07%-3.48pp | 13.55%+6.44pp | 7.11%-1.85pp | 8.96%-4.93pp | 13.89% |
| EPS | 17.18+691.7% | 2.17-42.9% | 3.80+75.9% | 2.16-89.2% | 20.06+1397.0% | 1.34-8.2% | 1.46-91.8% | 17.77 |
Corporate Events
Board MeetingNATHBIOGEN
202614Nov
Board Meeting
To consider and approve the unaudited financial results (sta…
BSE Filing ↗ Board MeetingNATHBIOGEN
202624Sep
Board Meeting
The 33rd Annual General Meeting (AGM) of the Company will be…
BSE Filing ↗ Board MeetingNATHBIOGEN
202629Jul
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗ Board MeetingNATHBIOGEN
202423Oct
Board Meeting
Consider, approve and take on record Unaudited Financial Res…
BSE Filing ↗ Board MeetingNATHBIOGEN
20248May
Board Meeting
Consider and approve Audited Financial Results for the 4th Q…
BSE Filing ↗ Board MeetingNATHBIOGEN
202418Jan
Board Meeting
Consider and approve Unaudited Financial Results
BSE Filing ↗ Board MeetingNATHBIOGEN
202316Oct
Board Meeting
Consider and approve of unaudited financial results as on 30…
BSE Filing ↗ Board MeetingNATHBIOGEN
202310Aug
Board Meeting
Consider and approve Unaudited financial results as on 30th …
BSE Filing ↗